Jun 2026 (Q2 FY26) — Aug 6, 2026
Himax Technologies Q2 FY26 — Strong Automotive IC Sales Drive Revenue and Margin Beat
Read the full callHimax Technologies (HIMX) earnings
- Jun 2026 (Q2 FY26)
- Dec 2017
Himax Technologies earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Price
$11.98 +2.83% · +$0.33
Performance +29.2% 1Y
1Y: $9.27 on 17 Oct 2025 → $11.98. High $24.19 (3 Jun 2026), low $6.93 (20 Nov 2025).
- Previous close
- $11.65
- 52-week range
- $6.93 – $24.19
- One year
- +25.84%
Overview
- Symbol
- HIMX
- Sector
- Information Technology
- Industry
- Semiconductors & Related Devices
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Himax Technologies earnings calls (HIMX)
Financials
What the filings say
| Line item | Dec 2016 | Dec 2017 |
|---|---|---|
| Equity capital | 107 | 107 |
| Total liabilities | 328 | 343 |
| Fixed assets | 48 | 87 |
| Total assets | 800 | 802 |
| Line item | Dec 2016 | Dec 2017 |
|---|---|---|
| Cash from operations | 85 | 29 |
| Cash from investing | -7 | -35 |
| Cash from financing | -23 | -41 |
| Capital expenditure | -8 | -40 |
| Free cash flow | 77 | -10 |
Insider filings
2 filings, all on Sep 30, 2026.
Open market
decisions to buy or sellNobody bought or sold HIMX on the open market in this window. The filings below are 2 option exercises.
Compensation
not trading decisions- 2
- Option exercise — converted options into shares
Latest filings (2)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Pan Ming-Feng Chief Financial Officer | Option exercise | 3,916 | $0 |
| Sep 30, 2026 | Wu Jordan President, CEO | Option exercise | 13,612 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Himax Technologies, Inc.
Free account. Everything above stays public.
Write why you follow Himax Technologies, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading